As of July 18, 2026, Endomorphin-1 is legal to sell at retail in Alabama. Unscheduled - legal as research-use-only; no operative instrument reaches a structurally-dissimilar opioid peptide. Controlling source: Ala. Code 20-2-23 (synthetic controlled substance analogue).
Verified July 18, 2026 · confidence: confirmedEndomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is not named or scheduled in Alabama. The state has a controlled-substance analogue/designer-drug statute whose effect prong can satisfy the test without structural similarity. It still does not operatively reach EM-1 as sold (see effect-prong scope / 'specifically designed' / human-consumption gate in the detail). Controlling instrument reviewed: Ala. Code 20-2-23 (synthetic controlled substance analogue). Conclusion: no operative instrument reaches a structurally-dissimilar endogenous opioid peptide; status LEGAL at the state controlled-substances level. Residual risk: low. Federal floor still applies (Analogue Act human-consumption contingency + FD&C unapproved-new-drug).
Ala. Code 20-2-23(5)(a): "A synthetic controlled substance analogue, being a material, mixture, or preparation that contains any chemical structure of which is chemically similar to the chemical structure of any other controlled substance in Schedule I or Schedule II OR that satisfies any one of the following: 1. Has a stimulant, depressant, or hallucinogenic effect on the central nervous system that mimics or is similar to or greater than [that] of a controlled substance in Schedule I or Schedule II; 2. [represents/intends and is actually capable of such effect]; 3. Has been demonstrated to have binding activity at one or more cannabinoid receptors; 4. Is capable of exhibiting cannabinoid-like activity ..." (b) excludes approved-new-drug / investigational substances; (c) "A controlled substance analogue is treated as a controlled substance in Schedule I." [Effect prong = stimulant/depressant/hallucinogenic or cannabinoid activity; opioid analgesia does not fit, and 'chemically similar' structure fails for a peptide.]
Among Alabama's 4 neighbors, Florida, Georgia, Mississippi and Tennessee are legal, the same posture as Alabama.
Open the interactive map · Every compound in Alabama
Not federally scheduled. Endomorphin-1 - not federally scheduled; endogenous opioid tetrapeptide, no CSA entry and no analogue-act structural hook Federal detail
1 instrument on file for this compound's framework in Alabama; 2 of 2 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
a86fb62a30d30727"(280) 4-Hydroxy-N-methyl-N-ethyltryptamine (Some trade or other names: 4-OH-MET) (State Control Mar. 18, 2014)" — Alabama Controlled Substances List (Board of Health Schedule I, Ala. Code § 20-2-23), official ADFS PDF: https://adfs.alabama.gov/Content/pdfs/drug-chemistry/2018%20Controlled%20Substance%20List.pdf
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap